Lancets and pen needles are essential components of diabetes management, used for blood glucose monitoring and insulin administration. Companies in the EMEA region involved in the production of lancets and pen needles typically focus on design, manufacturing, and distribution
Latest Europe Lancet and Pen Needles Companies Updates:
BD (US):Launched the BD Ultra-Fine Micro 6mm pen needles in Europe in July 2023, offering the world's thinnest pen needle for enhanced comfort during injections.Received EMA approval for its BD SoloStar® pen for Novo Nordisk's Ozempic® GLP-1 agonist medication, expanding its portfolio in diabetes management solutions.
Terumo Corporation (Japan):Partnered with Roche Diabetes Care in September 2023 to distribute their Accu-Chek® lancing devices and pen needles across Europe, expanding their market reach.Developed the FineTouch® lancing device with advanced vibration technology for reduced pain during blood glucose testing.
Owen Mumford (UK):Introduced the Echo® pen injector with voice guidance and Bluetooth connectivity in Europe in August 2023, enhancing accessibility and medication adherence for visually impaired users.Announced development of smart pen needles with integrated sensors to track injection data and improve therapy management.
Ypsomed Holding AG (Switzerland):Launched the mylife™ ClickPro lancing device with a comfortable grip and single-button activation in the Middle East in October 2023.Received positive feedback for their UnoPen™ insulin pen with a pre-filled cartridge system, gaining traction in the European market.
List of Europe Lancet and Pen Needles Key companies in the market:
Europe Lancet Pen Needles Market Highlights:
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)